Abstract
Characterization of CD4+ T-cell populations within the PDAC tumor microenvironment. A, Dot plot of the top markers expressed in each CD4+ T-cell cluster identified via Louvain clustering of scRNA-seq data from CD4+ T cells from 3 PDAC tumor tissue samples (i). Where identifiable in the data, clusters are annotated with known CD4+ T-cell phenotypes. UMAP embedding of CD4+ T cells overlaid with Louvain cluster labels (ii). B, A 35-parameter CyTOF analysis of CD45+ cells from PDAC patient PBMC and TIL (n = 10). t-SNE plots shows PhenoGraph-clustered CD4+ T-cell populations in PBMC and TIL. C, Stacked bar graph showing the proportion of Naïve, EM, CM, and TEMRA subsets in CD4+ T cells generated from the data in (B). D, Bar graph comparing the proportion of each annotated CD4+ EM subset (TEM1-5) in PBMC vs. TIL, generated using the data in (B). E, Differential expression analysis distinguishing CD4+ Th17 from other non-Treg CD4+ T-cells in scRNA-seq data, first presented in Fig. 1. Selected genes are labelled, and colored points indicate genes that are differentially expressed [BH adjusted P < 0.01 and absolute (average logFC) > 0.5]. F, Quantification of CD4+ Th17 based on dual expression of CCR6 and CD161, performed using the data in (B). Representative contour plots comparing Th17 in PBMC and TIL (i). Box and whisker plot comparing the proportion of Th17 among total memory (CD45RA–) non-Treg CD4+ T cells in PBMC and TIL (ii). G, Quantification of CD4+ Treg cells based on expression of CD25 and CD127, generated using the data in (B). Representative contour plot of Treg cells (CD25+CD127low) from PDAC TIL (i). Box and whisker plot comparing the proportion of Th17 cells in PBMC and TIL (ii). H, Histograms comparing expression levels of activation and differentiation markers on total Tregs from PBMC and TIL, generated using the data in (B). Horizontal lines represent median, boxes represent quartiles and whiskers represent minimum and maximum values. Data analyzed using Wilcoxon matched-pairs signed rank test. CyTOF comparisons analyzed using Wilcoxon matched-pairs signed rank test. *, P < 0.05; **, P < 0.01.